-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical Receives Multiple Prestigious Awards in Hebei Province’s Pharmaceutical Industry
Category:
Time：2020-12-14
On December 11, the third session, fourth meeting of the Board of Directors (extended) of the Hebei Province Pharmaceutical Industry Association—jointly hosted by the Hebei Province Pharmaceutical Industry Association and Shisi Pharmaceutical Group, the current chairperson unit of the association—was successfully held. Over 200 participants attended the meeting, including representatives from more than 100 pharmaceutical and commercial enterprises across the province as well as nearly 200 journalists from news media outlets. During the meeting, outstanding enterprises that have made remarkable contributions to the development of our province’s pharmaceutical industry were recognized and honored. The meeting was chaired by Qu Jiguang, the incumbent chairperson of the Hebei Province Pharmaceutical Industry Association for 2020 and Chairman of the Board of Directors of Shisi Pharmaceutical Group.
Shijiazhuang No.4 Pharmaceutical was awarded the honor of “Top Ten Pharmaceutical Manufacturers in Hebei Province for 2019” by the Association. The research projects of Shijiazhuang No.4 Pharmaceutical—“Key Technology Development and Application of Moxifloxacin Hydrochloride Sodium Chloride Injection,” “Development and Industrialization of Balanced Saline Irrigation Solution”—as well as the research project of Hebei Guolong Pharmaceutical, a subsidiary of Shijiazhuang No.4 Pharmaceutical Group—“Industrialized Development of a New Production Process for Hydroxyethyl Starch 130/0.4”—were awarded the First Prize for Pharmaceutical Science and Technology in Hebei Province for the 2018–2019 period.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license